Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01507584 · ClinicalTrials.gov registry record · NA

The Effects of the Water Drinking Test on Intraocular Pressure

A NA study of Glaucoma, sponsored by University of California, San Diego.

Completed
Registry status
NA
Development phase
23
Enrollment target
1
Study location

NCT01507584 is a NA study of Glaucoma that has completed, run by University of California, San Diego. The registered enrollment target is 23 participants, below the 910-participant average among 92 other Glaucoma trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01507584, a NA study of Glaucoma, has completed, sponsored by University of California, San Diego.

COMPLETED
Registry status
NA
Development phase
23 participants
Enrollment target
1
Study location

Study Summary

This clinical trial is designed to investigate the efficacy profile of the SENSIMED Triggerfish® during 24-hour IOP monitoring in patients with glaucoma or ocular hypertension, done three times at monthly intervals under different therapeutic regimen. This trial will also evaluate the efficacy of SENSIMED Triggerfish® to detect changes in intraocular pressure (IOP) after the water drinking test (WDT) will be investigated.

Conditions Studied

Interventions

  • DEVICE SENSIMED Triggerfish

Study Locations (1)

California

  • Hamilton Glaucoma Center, UCSD - La Jolla

Trial Details

FieldValue
Enrollment Target 23 participants
Start Date 2011-08
Est. Completion 2013-04-30
Phase NA

Sponsor

University of California, San Diego

775 total trials

What the Registry Record Tells You About NCT01507584

The ClinicalTrials.gov registry entry for NCT01507584 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 910-participant average among 92 other Glaucoma trials with a reported enrollment target (97% lower). The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Glaucoma appearing as the primary indexed condition, and to 1 intervention - of which SENSIMED Triggerfish is the first listed.

NCT01507584 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT01507584 about?

NCT01507584 is a clinical study titled "The Effects of the Water Drinking Test on Intraocular Pressure". This clinical trial is designed to investigate the efficacy profile of the SENSIMED Triggerfish® during 24-hour IOP monitoring in patients with glaucoma or ocular hypertension, done three times at monthly intervals under different therapeutic regimen. This trial will also evaluate the efficacy of SE...

What is the current status of trial NCT01507584?

This trial is currently completed. It is a NA study. The enrollment target is 23 participants. The study started on 2011-08. Estimated completion is 2013-04-30.

What conditions does trial NCT01507584 study?

This clinical trial studies the following conditions: Glaucoma.

What interventions are being tested in trial NCT01507584?

The interventions under investigation include: SENSIMED Triggerfish (DEVICE).

Who is sponsoring clinical trial NCT01507584?

This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01507584 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Glaucoma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.